What’s New

Home What’s New

03

Aug2023

PCPA Seeks Stakeholder Input On Its Proposed Process To Implement CADTH Time-Limited Recommendations

The pan-Canadian Pharmaceutical Alliance (pCPA) introduced its proposed pCPA Temporary Access Process (pTAP) and invited stakeholders’ input on ... Read More

11

Jul2023

Updates on PMPRB Activities in June 2023 NEWSletter

On June 6, 2023, the Patented Medicine Prices Review Board (PMPRB) released its first NEWSletter of 2023, providing ... Read More

11

Jul2023

CADTH Announces Changes to Reimbursement Reviews Process & Fee Schedule Update

On June 5, 2023, the Canadian Agency for Drugs and Technologies in Health (CADTH) announced a series of ... Read More

11

Jul2023

PMPRB Launches Consultation on its Amendment to the Interim Guidance RE: New Medicines

On June 20, 2023, PMPRB published proposed amendments to the Interim Guidance relating to  New Medicines. PMPRB has ... Read More